SARS-CoV-2–Specific Antibodies in Domestic Cats during First COVID-19 Wave, Europe

We conducted a severe acute respiratory syndrome coronavirus 2 antibody seroprevalence study among >2,000 domestic cats from 4 countries during the first coronavirus disease wave in Europe. We found 4.4% seroprevalence using a virus neutralization test and 4.3% using a receptor-binding domain EL...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Claudia Schulz, Byron Martina, Monica Mirolo, Elisabeth Müller, Ruth Klein, Holger Volk, Herman Egberink, Mariana Gonzalez-Hernandez, Franziska Kaiser, Maren von Köckritz-Blickwede, Albert Osterhaus
Formato:	article
Lenguaje:	EN
Publicado:	Centers for Disease Control and Prevention 2021
Materias:	COVID-19 cat Europe serology ELISA neutralization tests Medicine R Infectious and parasitic diseases RC109-216
Acceso en línea:	https://doaj.org/article/a4a62dd9270849cba39613524feb365a
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:a4a62dd9270849cba39613524feb365a
record_format	dspace
spelling	oai:doaj.org-article:a4a62dd9270849cba39613524feb365a2021-11-22T12:57:40ZSARS-CoV-2–Specific Antibodies in Domestic Cats during First COVID-19 Wave, Europe10.3201/eid2712.2112521080-60401080-6059https://doaj.org/article/a4a62dd9270849cba39613524feb365a2021-12-01T00:00:00Zhttps://wwwnc.cdc.gov/eid/article/27/12/21-1252_articlehttps://doaj.org/toc/1080-6040https://doaj.org/toc/1080-6059 We conducted a severe acute respiratory syndrome coronavirus 2 antibody seroprevalence study among >2,000 domestic cats from 4 countries during the first coronavirus disease wave in Europe. We found 4.4% seroprevalence using a virus neutralization test and 4.3% using a receptor-binding domain ELISA, demonstrating probable human-to-cat transmission. Claudia SchulzByron MartinaMonica MiroloElisabeth MüllerRuth KleinHolger VolkHerman EgberinkMariana Gonzalez-HernandezFranziska KaiserMaren von Köckritz-BlickwedeAlbert OsterhausCenters for Disease Control and PreventionarticleCOVID-19catEuropeserologyELISAneutralization testsMedicineRInfectious and parasitic diseasesRC109-216ENEmerging Infectious Diseases, Vol 27, Iss 12, Pp 3115-3118 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	COVID-19 cat Europe serology ELISA neutralization tests Medicine R Infectious and parasitic diseases RC109-216
spellingShingle	COVID-19 cat Europe serology ELISA neutralization tests Medicine R Infectious and parasitic diseases RC109-216 Claudia Schulz Byron Martina Monica Mirolo Elisabeth Müller Ruth Klein Holger Volk Herman Egberink Mariana Gonzalez-Hernandez Franziska Kaiser Maren von Köckritz-Blickwede Albert Osterhaus SARS-CoV-2–Specific Antibodies in Domestic Cats during First COVID-19 Wave, Europe
description	We conducted a severe acute respiratory syndrome coronavirus 2 antibody seroprevalence study among >2,000 domestic cats from 4 countries during the first coronavirus disease wave in Europe. We found 4.4% seroprevalence using a virus neutralization test and 4.3% using a receptor-binding domain ELISA, demonstrating probable human-to-cat transmission.
format	article
author	Claudia Schulz Byron Martina Monica Mirolo Elisabeth Müller Ruth Klein Holger Volk Herman Egberink Mariana Gonzalez-Hernandez Franziska Kaiser Maren von Köckritz-Blickwede Albert Osterhaus
author_facet	Claudia Schulz Byron Martina Monica Mirolo Elisabeth Müller Ruth Klein Holger Volk Herman Egberink Mariana Gonzalez-Hernandez Franziska Kaiser Maren von Köckritz-Blickwede Albert Osterhaus
author_sort	Claudia Schulz
title	SARS-CoV-2–Specific Antibodies in Domestic Cats during First COVID-19 Wave, Europe
title_short	SARS-CoV-2–Specific Antibodies in Domestic Cats during First COVID-19 Wave, Europe
title_full	SARS-CoV-2–Specific Antibodies in Domestic Cats during First COVID-19 Wave, Europe
title_fullStr	SARS-CoV-2–Specific Antibodies in Domestic Cats during First COVID-19 Wave, Europe
title_full_unstemmed	SARS-CoV-2–Specific Antibodies in Domestic Cats during First COVID-19 Wave, Europe
title_sort	sars-cov-2–specific antibodies in domestic cats during first covid-19 wave, europe
publisher	Centers for Disease Control and Prevention
publishDate	2021
url	https://doaj.org/article/a4a62dd9270849cba39613524feb365a
work_keys_str_mv	AT claudiaschulz sarscov2specificantibodiesindomesticcatsduringfirstcovid19waveeurope AT byronmartina sarscov2specificantibodiesindomesticcatsduringfirstcovid19waveeurope AT monicamirolo sarscov2specificantibodiesindomesticcatsduringfirstcovid19waveeurope AT elisabethmuller sarscov2specificantibodiesindomesticcatsduringfirstcovid19waveeurope AT ruthklein sarscov2specificantibodiesindomesticcatsduringfirstcovid19waveeurope AT holgervolk sarscov2specificantibodiesindomesticcatsduringfirstcovid19waveeurope AT hermanegberink sarscov2specificantibodiesindomesticcatsduringfirstcovid19waveeurope AT marianagonzalezhernandez sarscov2specificantibodiesindomesticcatsduringfirstcovid19waveeurope AT franziskakaiser sarscov2specificantibodiesindomesticcatsduringfirstcovid19waveeurope AT marenvonkockritzblickwede sarscov2specificantibodiesindomesticcatsduringfirstcovid19waveeurope AT albertosterhaus sarscov2specificantibodiesindomesticcatsduringfirstcovid19waveeurope
_version_	1718417571245457408

SARS-CoV-2–Specific Antibodies in Domestic Cats during First COVID-19 Wave, Europe

Ejemplares similares